Results 241 to 250 of about 156,533 (274)

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

BMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan, Qiujie Fang, Cao Fei, Ziyuan Wang, Zhaowei Chen, Guojun Chen, Zhiming Xu, Shu Xu, Zhitong Chen   +8 more
wiley   +1 more source

Can superficial parotid sparing alone impact xerostomia in head and neck cancer? A retrospective study correlating the type of tobacco use, chronic xerostomia, and parotid sparing. [PDF]

Rep Pract Oncol Radiother
Patil N, Chauhan S, Menon SS, Velu U, Singh A, Sharan K, Lewis S.   +6 more
europepmc   +1 more source

Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine

BMEMat, EarlyView.
Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo, Nan Li, Daiwei Zhang, Jingya Gu, Zhihuan Liao, Zihao Teng, Xiangfu Du, Peter S. Timashev, Shipeng Chen, Shuaidong Huo   +9 more
wiley   +1 more source

The risk of symptomatic radiation pneumonitis in small cell lung cancer patients following sequential immunochemotherapy and radiotherapy: a multicenter retrospective cohort study. [PDF]

Radiat Oncol
Liu Y, Zhang J, Zhang M, Wu W, Zhang H, Yin H.   +5 more
europepmc   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Radiation Therapy for Maxillary Sinus Epithelioid Hemangioendothelioma: A Case Report and Literature Review. [PDF]

Cureus
Ichou S, Lachgar A, Skitioui I, Nouni K, Elkacemi H, Kebdani T, Hassouni K.   +6 more
europepmc   +1 more source

Dose-dependent taste dysfunction in head and neck cancer patients receiving radiotherapy. [PDF]

Radiat Oncol
Zhang SM, Li FY, Hao MY, Yang YX, Xiong YX, Chuah YZ, Chi F, Wang GY, Qi LP, Zhou D, Jia LC, Li H, Liu YF, Sun Y, Guo R, Zhou GQ.   +15 more
europepmc   +1 more source

Radiotherapy for Liver-Confined Hepatocellular Carcinoma in Elderly Patients with Comorbidity. [PDF]

Cancers (Basel)
Bae SH, Kim YS, Kim SG, Yoo JJ, Lee JM, Lim S, Jung JH, Kim CK.   +7 more
europepmc   +1 more source

Blame It on My (Arterial) Youth: How Childhood Vascular Morphology Shapes the Risk of Cerebral Vasculopathy in Sickle Cell Disease

American Journal of Hematology, EarlyView.
Thomas Pincez
wiley   +1 more source

Application of Unlaminated Gafchromic EBT3 Film for Surface Dose Measurement in Breast Radiotherapy. [PDF]

J Med Phys
Kakade NR, Kumar R, Srivastava A, Pilakkal S, Sharma SD, Sapra BK.   +5 more
europepmc   +1 more source